Diagnostics

Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs – a scoping review of the qualitative evidence More

Pharmacies can provide easy access to hepatitis C testing for people who inject drugs, helping to control infection rates and allow the elimination of the virus in England by 2025. More

Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot More

Dried blood and plasma samples (DBS and DPS) are useful alternative for hepatitis C detection in settings lacking adequate infrastructure. More

CDC recommended that the use of strategies requiring multiple visits to collect blood for hepatitis C virus testing should be discontinued and replaced by single-visit sample collection. More

Rapid on-site testing for hepatitis C at a supervised injection site in Canada led to greater engagement and linkage to care among people who inject drugs, improving the likelihood of getting treated. More

Genetic diversity of hepatitis B and C viruses revealed by continuous surveillance from 2015 to 2021 in Gabon, Central Africa More

Seroprevalence and associated risk factors of hepatitis C infection among diabetic patients in South-Kivu, Eastern Democratic Republic of the Congo: A cross-sectional study More

Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis More

A study evaluated the temporal trend of HCV-positive pregnancies during the opioid epidemic and identified HCV-associated maternal and perinatal outcomes. More